JAMES P ALLISON to Receptors, Interleukin-2
This is a "connection" page, showing publications JAMES P ALLISON has written about Receptors, Interleukin-2.
Connection Strength
0.190
-
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015 Feb; 25(2):208-24.
Score: 0.119
-
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses. Proc Natl Acad Sci U S A. 2012 Jan 17; 109(3):881-6.
Score: 0.024
-
Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes. Nature. 1987 Nov 12-18; 330(6144):170-3.
Score: 0.018
-
CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1. Blood. 2004 Jun 15; 103(12):4594-601.
Score: 0.014
-
B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections]. J Immunol. 2004 Jan 01; 172(1):34-9.
Score: 0.014